Fenoldopam: Difference between revisions

Jump to navigation Jump to search
m (Protected "Fenoldopam": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
Line 23: Line 23:
{{CMG}}
{{CMG}}


{{Editor Join}}
 


==Overview==
==Overview==
Line 34: Line 34:
[[Category:Pharmacology]]
[[Category:Pharmacology]]
[[Category:Drugs]]
[[Category:Drugs]]
{{SIB}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 02:39, 9 August 2012

Fenoldopam
Clinical data
[[Regulation of therapeutic goods |Template:Engvar data]]
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
Intravenous
ATC code
Pharmacokinetic data
Bioavailabilityn/a
MetabolismHepatic (CYP not involved)
Elimination half-life5 minutes
ExcretionRenal (90%) and fecal (10%)
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H16ClNO3
Molar mass305.756 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Fenoldopam is a synthetic compound that acts as a selective peripheral dopamine D1A receptor agonist. Fenoldopam is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation, decreasing afterload and also through specific dopamine receptors along the nephron promoting sodium excretion.

Template:Dopamine agonists Template:Adrenergic and dopaminergic agents


Template:WikiDoc Sources